SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5ir3'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZR_A_H4BA760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.20A	1zzrA-5ir3A: undetectable 1zzrB-5ir3A: undetectable	1zzrA-5ir3A: 14.35 1zzrB-5ir3A: 14.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZR_B_H4BB761_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.19A	1zzrA-5ir3A: undetectable 1zzrB-5ir3A: undetectable	1zzrA-5ir3A: 14.35 1zzrB-5ir3A: 14.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_A_H4BA760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.19A	1zzuA-5ir3A: undetectable 1zzuB-5ir3A: undetectable	1zzuA-5ir3A: 14.35 1zzuB-5ir3A: 14.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_B_H4BB761_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.19A	1zzuA-5ir3A: undetectable 1zzuB-5ir3A: undetectable	1zzuA-5ir3A: 14.35 1zzuB-5ir3A: 14.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCAN LYASE ISOZYME 1)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	5 / 10	PHE A 20 SER A 75 SER A 66 TRP A 36 GLY A 103	None	1.38A	2x2iB-5ir3A: undetectable	2x2iB-5ir3A: 8.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DQR_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.23A	3dqrA-5ir3A: undetectable 3dqrB-5ir3A: undetectable	3dqrA-5ir3A: 14.70 3dqrB-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DQR_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.27A	3dqrA-5ir3A: undetectable 3dqrB-5ir3A: undetectable	3dqrA-5ir3A: 14.70 3dqrB-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX2_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.15A	3jx2A-5ir3A: undetectable 3jx2B-5ir3A: undetectable	3jx2A-5ir3A: 14.70 3jx2B-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX2_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.19A	3jx2A-5ir3A: undetectable 3jx2B-5ir3A: undetectable	3jx2A-5ir3A: 14.70 3jx2B-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.19A	3jx3A-5ir3A: undetectable 3jx3B-5ir3A: undetectable	3jx3A-5ir3A: 14.70 3jx3B-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.16A	3jx3A-5ir3A: undetectable 3jx3B-5ir3A: undetectable	3jx3A-5ir3A: 14.70 3jx3B-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.22A	3jx4A-5ir3A: undetectable 3jx4B-5ir3A: undetectable	3jx4A-5ir3A: 14.70 3jx4B-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX5_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.17A	3jx5A-5ir3A: undetectable 3jx5B-5ir3A: undetectable	3jx5A-5ir3A: 14.70 3jx5B-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX5_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.21A	3jx5A-5ir3A: undetectable 3jx5B-5ir3A: undetectable	3jx5A-5ir3A: 14.70 3jx5B-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX6_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.13A	3jx6A-5ir3A: undetectable 3jx6B-5ir3A: undetectable	3jx6A-5ir3A: 14.70 3jx6B-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX6_B_H4BB761_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.17A	3jx6A-5ir3A: undetectable 3jx6B-5ir3A: undetectable	3jx6A-5ir3A: 14.70 3jx6B-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLJ_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.14A	3nljA-5ir3A: undetectable 3nljB-5ir3A: undetectable	3nljA-5ir3A: 14.70 3nljB-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLJ_B_H4BB761_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.15A	3nljA-5ir3A: undetectable 3nljB-5ir3A: undetectable	3nljA-5ir3A: 14.70 3nljB-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLP_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.15A	3nlpA-5ir3A: undetectable 3nlpB-5ir3A: undetectable	3nlpA-5ir3A: 14.70 3nlpB-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLP_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.19A	3nlpA-5ir3A: undetectable 3nlpB-5ir3A: undetectable	3nlpA-5ir3A: 14.70 3nlpB-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLQ_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 8	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.14A	3nlqA-5ir3A: undetectable 3nlqB-5ir3A: undetectable	3nlqA-5ir3A: 14.70 3nlqB-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLR_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.16A	3nlrA-5ir3A: undetectable 3nlrB-5ir3A: undetectable	3nlrA-5ir3A: 14.70 3nlrB-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX3_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.21A	4cx3A-5ir3A: undetectable 4cx3B-5ir3A: undetectable	4cx3A-5ir3A: 14.70 4cx3B-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.18A	4cx3A-5ir3A: undetectable 4cx3B-5ir3A: undetectable	4cx3A-5ir3A: 14.70 4cx3B-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.20A	4cx4A-5ir3A: undetectable 4cx4B-5ir3A: undetectable	4cx4A-5ir3A: 14.70 4cx4B-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.19A	4cx4A-5ir3A: undetectable 4cx4B-5ir3A: undetectable	4cx4A-5ir3A: 14.70 4cx4B-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADD_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.17A	5addA-5ir3A: undetectable 5addB-5ir3A: undetectable	5addA-5ir3A: 14.70 5addB-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	VAL A 110 ARG A 62 VAL A 18 GLU A 86	None	1.21A	5g0pA-5ir3A: undetectable 5g0pB-5ir3A: undetectable	5g0pA-5ir3A: 14.70 5g0pB-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 7	GLU A 86 VAL A 110 ARG A 62 VAL A 18	None	1.24A	5g0pA-5ir3A: undetectable 5g0pB-5ir3A: undetectable	5g0pA-5ir3A: 14.70 5g0pB-5ir3A: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JSD_A_1GNA615_1 (PHIAB6 TAILSPIKE)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	3 / 3	TYR A 94 TYR A 37 GLN A 35	ACT A 201 (-4.2A) None None	1.07A	5jsdA-5ir3A: 2.5 5jsdB-5ir3A: undetectable	5jsdA-5ir3A: 11.45 5jsdB-5ir3A: 11.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JSD_B_1GNB606_1 (PHIAB6 TAILSPIKE)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	3 / 3	TYR A 94 TYR A 37 GLN A 35	ACT A 201 (-4.2A) None None	1.06A	5jsdB-5ir3A: undetectable 5jsdC-5ir3A: 1.2	5jsdB-5ir3A: 11.45 5jsdC-5ir3A: 11.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EKU_A_ZMRA901_2 (SIALIDASE)	5ir3	IG LAMBDA CHAIN V-VI REGION AR (Homo sapiens)	4 / 6	ASP A 69 LEU A 4 SER A 93 PHE A 2	None	1.26A	6ekuA-5ir3A: undetectable	6ekuA-5ir3A: 10.50

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1ZZR_A_H4BA760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.20A","1zzrA-5ir3A:undetectable;1zzrB-5ir3A:undetectable","1zzrA-5ir3A:14.35;1zzrB-5ir3A:14.35"],["1ZZR_B_H4BB761_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.19A","1zzrA-5ir3A:undetectable;1zzrB-5ir3A:undetectable","1zzrA-5ir3A:14.35;1zzrB-5ir3A:14.35"],["1ZZU_A_H4BA760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.19A","1zzuA-5ir3A:undetectable;1zzuB-5ir3A:undetectable","1zzuA-5ir3A:14.35;1zzuB-5ir3A:14.35"],["1ZZU_B_H4BB761_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.19A","1zzuA-5ir3A:undetectable;1zzuB-5ir3A:undetectable","1zzuA-5ir3A:14.35;1zzuB-5ir3A:14.35"],["2X2I_B_QPSB1060_1","ALPHA-1,4-GLUCAN LYASE ISOZYME 1","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",5,"PHE A  20;SER A  75;SER A  66;TRP A  36;GLY A 103","None","1.38A","2x2iB-5ir3A:undetectable","2x2iB-5ir3A:8.04"],["3DQR_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.23A","3dqrA-5ir3A:undetectable;3dqrB-5ir3A:undetectable","3dqrA-5ir3A:14.70;3dqrB-5ir3A:14.70"],["3DQR_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.27A","3dqrA-5ir3A:undetectable;3dqrB-5ir3A:undetectable","3dqrA-5ir3A:14.70;3dqrB-5ir3A:14.70"],["3JX2_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.15A","3jx2A-5ir3A:undetectable;3jx2B-5ir3A:undetectable","3jx2A-5ir3A:14.70;3jx2B-5ir3A:14.70"],["3JX2_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.19A","3jx2A-5ir3A:undetectable;3jx2B-5ir3A:undetectable","3jx2A-5ir3A:14.70;3jx2B-5ir3A:14.70"],["3JX3_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.19A","3jx3A-5ir3A:undetectable;3jx3B-5ir3A:undetectable","3jx3A-5ir3A:14.70;3jx3B-5ir3A:14.70"],["3JX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.16A","3jx3A-5ir3A:undetectable;3jx3B-5ir3A:undetectable","3jx3A-5ir3A:14.70;3jx3B-5ir3A:14.70"],["3JX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.22A","3jx4A-5ir3A:undetectable;3jx4B-5ir3A:undetectable","3jx4A-5ir3A:14.70;3jx4B-5ir3A:14.70"],["3JX5_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.17A","3jx5A-5ir3A:undetectable;3jx5B-5ir3A:undetectable","3jx5A-5ir3A:14.70;3jx5B-5ir3A:14.70"],["3JX5_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.21A","3jx5A-5ir3A:undetectable;3jx5B-5ir3A:undetectable","3jx5A-5ir3A:14.70;3jx5B-5ir3A:14.70"],["3JX6_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.13A","3jx6A-5ir3A:undetectable;3jx6B-5ir3A:undetectable","3jx6A-5ir3A:14.70;3jx6B-5ir3A:14.70"],["3JX6_B_H4BB761_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.17A","3jx6A-5ir3A:undetectable;3jx6B-5ir3A:undetectable","3jx6A-5ir3A:14.70;3jx6B-5ir3A:14.70"],["3NLJ_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.14A","3nljA-5ir3A:undetectable;3nljB-5ir3A:undetectable","3nljA-5ir3A:14.70;3nljB-5ir3A:14.70"],["3NLJ_B_H4BB761_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.15A","3nljA-5ir3A:undetectable;3nljB-5ir3A:undetectable","3nljA-5ir3A:14.70;3nljB-5ir3A:14.70"],["3NLP_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.15A","3nlpA-5ir3A:undetectable;3nlpB-5ir3A:undetectable","3nlpA-5ir3A:14.70;3nlpB-5ir3A:14.70"],["3NLP_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.19A","3nlpA-5ir3A:undetectable;3nlpB-5ir3A:undetectable","3nlpA-5ir3A:14.70;3nlpB-5ir3A:14.70"],["3NLQ_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.14A","3nlqA-5ir3A:undetectable;3nlqB-5ir3A:undetectable","3nlqA-5ir3A:14.70;3nlqB-5ir3A:14.70"],["3NLR_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.16A","3nlrA-5ir3A:undetectable;3nlrB-5ir3A:undetectable","3nlrA-5ir3A:14.70;3nlrB-5ir3A:14.70"],["4CX3_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.21A","4cx3A-5ir3A:undetectable;4cx3B-5ir3A:undetectable","4cx3A-5ir3A:14.70;4cx3B-5ir3A:14.70"],["4CX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.18A","4cx3A-5ir3A:undetectable;4cx3B-5ir3A:undetectable","4cx3A-5ir3A:14.70;4cx3B-5ir3A:14.70"],["4CX4_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.20A","4cx4A-5ir3A:undetectable;4cx4B-5ir3A:undetectable","4cx4A-5ir3A:14.70;4cx4B-5ir3A:14.70"],["4CX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.19A","4cx4A-5ir3A:undetectable;4cx4B-5ir3A:undetectable","4cx4A-5ir3A:14.70;4cx4B-5ir3A:14.70"],["5ADD_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.17A","5addA-5ir3A:undetectable;5addB-5ir3A:undetectable","5addA-5ir3A:14.70;5addB-5ir3A:14.70"],["5G0P_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"VAL A 110;ARG A  62;VAL A  18;GLU A  86","None","1.21A","5g0pA-5ir3A:undetectable;5g0pB-5ir3A:undetectable","5g0pA-5ir3A:14.70;5g0pB-5ir3A:14.70"],["5G0P_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"GLU A  86;VAL A 110;ARG A  62;VAL A  18","None","1.24A","5g0pA-5ir3A:undetectable;5g0pB-5ir3A:undetectable","5g0pA-5ir3A:14.70;5g0pB-5ir3A:14.70"],["5JSD_A_1GNA615_1","PHIAB6 TAILSPIKE;PHIAB6 TAILSPIKE","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",3,"TYR A  94;TYR A  37;GLN A  35","ACT A 201 (-4.2A);None;None","1.07A","5jsdA-5ir3A:2.5;5jsdB-5ir3A:undetectable","5jsdA-5ir3A:11.45;5jsdB-5ir3A:11.45"],["5JSD_B_1GNB606_1","PHIAB6 TAILSPIKE;PHIAB6 TAILSPIKE","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",3,"TYR A  94;TYR A  37;GLN A  35","ACT A 201 (-4.2A);None;None","1.06A","5jsdB-5ir3A:undetectable;5jsdC-5ir3A:1.2","5jsdB-5ir3A:11.45;5jsdC-5ir3A:11.45"],["6EKU_A_ZMRA901_2","SIALIDASE","5ir3","IG LAMBDA CHAIN V-VI REGION AR","Homo sapiens",4,"ASP A  69;LEU A   4;SER A  93;PHE A   2","None","1.26A","6ekuA-5ir3A:undetectable","6ekuA-5ir3A:10.50"]]